• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bliss GVS Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 79.0
  • ISIN : INE416D01022
173.73 -3 (-1.47%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    172.65

  • Today’s High

    178.80

  • Open

    175.20

  • Perv Close

    176.33

  • 52W Low

    106.04

  • 52W High

    190.97

Key Indicators

  • P/E(TTM)

    25.96

  • Mar.Cap (₹Cr.)

    1,832.81

  • Div & Yield %

    0.29

  • Book Value(₹)

    100.35

  • Debt-Equity Ratio

    -1.47

  • AGM Date

    01-Aug-2025

  • EPS

    6.69

  • P/E Ratio

    25.96

Financials Ratios

  • Debt-Equity Ratio

    0.11

  • Mar.Cap (₹Cr.)

    1,832.81

  • RONW (%)

    11.02

  • ROCE (%)

    14.84

Score Board

  • Equity (₹ in Cr.)

    10.55

  • BV (₹)

    100.30

  • Sales( ₹ in Cr.)

    667.20

  • NP (in Cr.)

    69.11

  • NP Var(%)

    -9.0

  • Div%

    50.0

  • CPS (₹)

    9.10

  • EPS (₹)

    6.60

  • Traded Value (₹ in Lakhs)

    1,832.49

  • 52 Week High

    190.97

  • 52 Week Low

    106.04

  • Price BSE

    174.0

  • Price NSE

    174.00

  • Market Capital( in Cr.)

    1,832.49

  • P/C Ratio

    19.10

  • P/E Ratio

    26.60

  • Price Vs.BV

    6.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 667.20 605.46 598.34 636.36 465.51 441.95
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 667.20 605.46 598.34 636.36 465.51 441.95
Other Income 36.22 33.50 50.77 35.37 17.68 37.00
Stock Adjustments -6.63 6.36 -21.24 8.90 8.85 -2.37
Total Income 696.79 645.32 627.87 680.63 492.04 476.58
EXPENDITURE :            
Raw Materials 339.47 305.83 293.66 352.84 262.15 234.36
Power and Fuel Cost 9.76 8.81 5.80 7.09 6.99 4.70
Employee Cost 99.42 82.59 72.54 65.06 58.61 44.02
Other Manufacturing Expenses 15.50 17.25 11.57 11.54 7.49 6.23
Selling and Administration Expenses 76.23 66.73 66.90 67.07 36.90 36.23
Miscellaneous Expenses 28.61 64.52 36.48 32.45 10.76 13.88
Employee Benefit Expenses 99.42 82.59 72.54 65.06 58.61 44.02
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 568.98 545.74 486.95 536.05 382.90 339.42
Operating Profit 127.80 99.59 140.93 144.57 109.14 137.16
Interest 6.58 5.81 10.06 4.32 4.19 6.62
Gross Profit 121.22 93.78 130.87 140.25 104.95 130.54
Depreciation 27.05 23.52 15.17 13.85 13.76 8.83
Profit Before Tax 94.17 70.26 115.70 126.40 91.19 121.71
Current Tax 30.74 26.34 34.42 31.92 21.52 31.81
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -5.54 -6.72 -4.21 1.81 2.16 -2.44
Reported Net Profit 68.97 50.64 85.48 92.66 67.50 92.33
Extraordinary Items -0.14 -25.47 0.26 2.09 -0.02 0.53
Adjusted Net Profit 69.11 76.11 85.22 90.57 67.52 91.80
Adjustment below Net Profit -0.56 -0.15 -0.67 0.30 0.52 -0.26
P & L Balance brought forward 892.57 846.18 765.33 676.22 613.36 533.69
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 4.12 4.10 3.97 3.86 5.16 12.41
P & L Balance carried down 956.86 892.57 846.18 765.33 676.22 613.36
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 50.00 50.00 50.00 50.00 50.00
Dividend Per Share(Rs) 0.50 0.50 0.50 0.50 0.50 0.50
Earnings Per Share-Unit Curr 6.55 4.84 8.21 8.94 6.54 8.95
Earnings Per Share(Adj)-Unit Curr 6.55 4.84 8.21 8.94 6.54 8.95
Book Value 100.47 94.41 89.96 82.12 73.26 66.21
Book Value(Adj)-Unit Curr 100.47 94.41 89.96 82.12 73.26 66.21

Shareholding Pattern

  • Promoter Group

    35.44%

  • Public Share Holding

    64.56%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,387,174 35.44 37,387,174 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37,387,174 35.44 37,387,174 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 13,348,130 12.65 13,348,130 41
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,901,355 6.54 6,901,355 1
Mutual Funds / UTI 2,443 0.00 2,443 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,251,928 19.20 20,251,928 44
2] Non Institution
Bodies Corporate 7,822,910 7.42 7,778,470 205
Clearing Members 1 0.00 1 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,312,525 1.24 1,231,005 737
Foreign Non Institution Other 200 0.00 200 1
Hindu Undivided Families 1,280,886 1.21 1,280,886 857
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11,167,680 10.59 11,167,680 9
Individuals holding nominal share capital up to Rs. 1 lakh 23,420,735 22.20 22,081,883 44,819
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,614,527 2.48 2,599,277 3
Sub Total 47,858,420 45.36 46,378,358 46,655
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 105,497,522 100.00 104,017,460 46,707

Company Background

Bliss GVS Pharma LtdPharmaceuticals - Indian - Formulations

  • Bliss GVS Pharma Ltd
  • BSE Code : 79.0
  • ISIN : INE416D01022

  • Incorporation Year

    1984

  • Registered Office

    102 Hyde Park Sakivihar Road
    Andheri East, Mumbai,
    Maharashtra-400072

  • Telephone

    91-22-42160000

  • FAX

    91-22-28563930

  • Chairman

    Nandkumar Kashinath Chodankar

  • Managing Director

    Gagan Harsh Sharmma

  • Company Secretary

    Aditi Bhatt

  • Auditor

    Kalyaniwalla & Mistry LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Bliss GVS Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Novartis India 967.25 398.23 356.27 23.23 16.64
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10